EFA - ETF AI Analysis
Top Page
iShares MSCI EAFE ETF (EFA)
Rating:66Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many developed countries like Japan, the UK, France, and Germany, which helps reduce the impact of problems in any single market.
Strong Contribution from Key Holdings
Several of the largest positions, such as ASML, Roche, Novartis, Siemens, Toyota, and HSBC, have shown solid gains this year, supporting the ETF’s overall performance.
Balanced Sector Mix
Holdings are spread across financials, industrials, health care, technology, and other sectors, which can help smooth returns when one industry is struggling.
Negative Factors
Meaningful Exposure to Lagging Stocks
Some top holdings like Nestlé, SAP, AstraZeneca, and Shell have been weak this year, which can drag on the fund’s results if the trend continues.
Heavy Tilt Toward Financials and Industrials
A large share of the portfolio is in financial and industrial companies, so a downturn in these sectors could hurt the ETF more than a more evenly balanced fund.
Moderate Expense Ratio
The fund’s fees are not especially low for a large, broad international ETF, which slightly reduces the net return investors keep over time.
EFA vs. SPDR S&P 500 ETF (SPY)
AUM70.60B
RegionDeveloped Markets
Expense Ratio0.32%
Beta0.76
IssueriShares
Inception DateAug 14, 2001
Dividend Yield3.41%
Asset ClassEquity
Index TrackedMSCI EAFE
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume28,789,935
30 Day Avg. Volume24,105,708
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
111.03Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering683
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EFA Summary
The iShares MSCI EAFE ETF (EFA) is a fund that follows the MSCI EAFE Index, which tracks stocks from developed countries outside the U.S. and Canada, such as Japan, the UK, and Europe. It owns many large, well-known companies like Toyota, Nestlé, and AstraZeneca across sectors including financials, industrials, and healthcare. Someone might invest in EFA to diversify their portfolio internationally and reduce reliance on the U.S. market while seeking long-term growth from established global economies. A key risk is that its value can rise or fall with international stock markets and currency movements.
How much will it cost me?The iShares MSCI EAFE ETF (EFA) has an expense ratio of 0.32%, meaning you’ll pay $3.20 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it provides broad exposure to developed international markets, which can involve higher operational costs compared to U.S.-focused funds.
What would affect this ETF?The iShares MSCI EAFE ETF could benefit from economic recovery in developed markets outside North America, particularly in Europe and Asia, as well as growth in sectors like financials and technology, which are heavily represented in its holdings. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially in sectors like financials and energy. Diversification across industries and countries provides some resilience, but global economic uncertainty remains a key risk.
EFA Top 10 Holdings
EFA leans heavily on overseas blue chips, with Europe and Japan doing most of the talking. ASML has been a key engine, rising over the past few months and giving the fund a tech-powered boost despite some recent choppiness. Shell has also been climbing, helping offset weakness elsewhere. On the flip side, defensive giants like Nestlé and pharma heavyweight Roche have been lagging, acting more like a brake than a motor. Financials such as HSBC and Mitsubishi UFJ look mixed, underscoring EFA’s broad but non-U.S., non-Canada developed-market focus.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.54% | $1.75B | €448.98B | 74.58% | 76 Outperform | |
| AstraZeneca | 1.44% | $987.43M | $285.86B | 22.04% | 80 Outperform | |
| Novartis AG | 1.40% | $961.07M | CHF221.00B | 20.02% | 80 Outperform | |
| Roche Holding AG | 1.34% | $921.37M | $307.76B | 14.80% | ― | |
| HSBC Holdings | 1.32% | $903.47M | £203.18B | 32.83% | 80 Outperform | |
| Shell (UK) | 1.30% | $894.92M | £188.61B | 25.14% | 73 Outperform | |
| Nestlé SA | 1.24% | $854.99M | CHF193.44B | -4.15% | 71 Outperform | |
| Commonwealth Bank of Australia | 1.03% | $706.51M | AU$291.31B | 15.13% | 64 Neutral | |
| Toyota Motor | 0.97% | $668.19M | ¥42.63T | 13.48% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 0.93% | $640.72M | ¥29.51T | 19.31% | 76 Outperform |
EFA Technical Analysis
Neutral
―
Price Trends
100.72
Negative
97.56
Negative
93.57
Positive
Market Momentum
-1.67
Positive
42.73
Neutral
47.30
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFA, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 98.76, equal to the 50-day MA of 100.72, and equal to the 200-day MA of 93.57, indicating a neutral trend. The MACD of -1.67 indicates Positive momentum. The RSI at 42.73 is Neutral, neither overbought nor oversold. The STOCH value of 47.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for EFA.
EFA Peer Comparison
Comparison Results
Performance Comparison
EFA
iShares MSCI EAFE ETF
96.66
16.51
20.60%
IEFA
iShares Core MSCI EAFE ETF
―
―
―
EFV
iShares MSCI EAFE Value ETF
―
―
―
EFG
iShares MSCI EAFE Growth ETF
―
―
―
SCZ
iShares MSCI EAFE Small-Cap ETF
―
―
―
ESGD
iShares ESG Aware MSCI EAFE ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents